Company Filing History:
1 out of 712 
1 out of 45 
1 out of 11 Years Active: 1998-2019
Title: David Andreu: Innovator in Antimicrobial Peptides
Introduction
David Andreu is a prominent inventor based in Barcelona, Spain. He has made significant contributions to the field of antimicrobial peptides, focusing on innovative solutions for treating infections. With a total of 2 patents, his work is paving the way for advancements in medical treatments.
Latest Patents
One of his latest patents is an antimicrobial peptide designed for nosocomial infections. This novel peptide exhibits an inhibitory effect on biofilms produced by biofilm-forming bacteria. It is effective against a wide range of bacterial targets, generates no antimicrobial resistance, and agglutinates bacterial cells to enhance pathogen removal at the infectious focus. Additionally, it promotes biofilm eradication and prevents biofilm development. Compositions comprising this peptide are intended for treating and preventing infectious diseases, as well as for disinfecting medical and surgical materials.
Another significant invention by Andreu involves antibacterial and antimalarial hybrid peptides. These hybrid peptides are derived from naturally occurring peptides such as cecropins, attacins, magainins, sarcotoxin, sapecin, bactenecins, alamethidicins, defensins, and PGLa, along with toxins like streptolysins, melittin, barbatolysin, paradaxins, and delta hemolysin. The hybrid peptides are easily synthesized and exhibit reduced toxicity. This invention also includes pharmaceutical compositions containing these hybrid peptides and methods for treating patients infected with organisms against which these peptides are effective.
Career Highlights
David Andreu has worked with esteemed institutions such as The Rockefeller University and Universitat Autonoma de Barcelona. His career reflects a commitment to advancing scientific knowledge and developing practical applications for his research.
Collaborations
Throughout his career, Andreu has collaborated with notable scientists, including Hans G. Boman and Robert B. Merrifield. These collaborations have contributed to the depth and impact of his research in the field of antimicrobial peptides.
Conclusion
David Andreu's innovative work in antimicrobial peptides showcases his dedication to addressing critical health challenges. His patents reflect a significant advancement in the fight against infections, highlighting the importance of continued research and development in this vital area.